Holen Sie sich die Stockscreener-App
24.52
0.49%
-0.12
Handel nachbörslich:
24.52
Schlusskurs vom Vortag:
$24.64
Offen:
$24.84
24-Stunden-Volumen:
651.07K
Relative Volume:
1.19
Marktkapitalisierung:
$2.94B
Einnahmen:
$1.72B
Nettoeinkommen (Verlust:
$12.82M
KGV:
245.20
EPS:
0.1
Netto-Cashflow:
$98.59M
1W Leistung:
-2.85%
1M Leistung:
+7.88%
6M Leistung:
+26.20%
1J Leistung:
+20.02%
1-Tages-Spanne:
$24.43
$25.15
1-Wochen-Bereich:
$24.43
$25.67
52-Wochen-Spanne:
$15.92
$25.67
Privia Health Group Inc Stock (PRVA) Company Profile
Firmenname
Privia Health Group Inc
Sektor
Branche
Telefon
571-366-8850
Adresse
950 N. GLEBE RD., SUITE 700, ARLINGTON
Vergleichen Sie PRVA mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
PRVA
Privia Health Group Inc
|
24.52 | 2.94B | 1.72B | 12.82M | 98.59M | 0.10 |
|
VEEV
Veeva Systems Inc
|
225.79 | 36.66B | 2.66B | 665.91M | 1.08B | 4.05 |
|
DOCS
Doximity Inc
|
72.37 | 13.58B | 516.85M | 174.11M | 217.38M | 0.87 |
|
SOLV
Solventum Corp
|
73.02 | 12.61B | 8.26B | 66.00M | 1.17B | 0.3682 |
|
TEM
Tempus Ai Inc
|
68.09 | 10.72B | 640.44M | -743.28M | -206.93M | -11.29 |
|
HQY
Healthequity Inc
|
108.60 | 9.41B | 1.15B | 96.70M | -161.99M | 1.09 |
Privia Health Group Inc Stock (PRVA) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-01-10 | Eingeleitet | Needham | Buy |
| 2024-12-16 | Eingeleitet | Macquarie | Outperform |
| 2024-10-11 | Eingeleitet | KeyBanc Capital Markets | Overweight |
| 2024-05-30 | Eingeleitet | Robert W. Baird | Outperform |
| 2024-04-22 | Eingeleitet | Citigroup | Buy |
| 2024-03-06 | Eingeleitet | Barclays | Equal Weight |
| 2024-02-26 | Fortgesetzt | Jefferies | Buy |
| 2024-02-22 | Herabstufung | BofA Securities | Buy → Neutral |
| 2023-12-06 | Eingeleitet | JMP Securities | Mkt Outperform |
| 2023-06-13 | Eingeleitet | Evercore ISI | Outperform |
| 2023-04-12 | Eingeleitet | Stephens | Overweight |
| 2023-03-10 | Eingeleitet | RBC Capital Mkts | Outperform |
| 2023-02-03 | Eingeleitet | Goldman | Buy |
| 2022-12-09 | Eingeleitet | Stifel | Buy |
| 2022-12-08 | Eingeleitet | UBS | Buy |
| 2022-09-07 | Fortgesetzt | Truist | Buy |
| 2022-05-03 | Eingeleitet | BofA Securities | Buy |
| 2022-04-28 | Eingeleitet | BTIG Research | Buy |
| 2022-04-01 | Fortgesetzt | Credit Suisse | Outperform |
| 2022-03-30 | Eingeleitet | Guggenheim | Buy |
| 2022-02-22 | Hochstufung | Cowen | Market Perform → Outperform |
| 2022-01-03 | Eingeleitet | Jefferies | Buy |
| 2021-09-27 | Eingeleitet | SVB Leerink | Outperform |
| 2021-09-10 | Eingeleitet | Cowen | Market Perform |
| 2021-05-24 | Eingeleitet | Canaccord Genuity | Buy |
| 2021-05-24 | Eingeleitet | Credit Suisse | Outperform |
| 2021-05-24 | Eingeleitet | JP Morgan | Overweight |
| 2021-05-24 | Eingeleitet | Piper Sandler | Overweight |
| 2021-05-24 | Eingeleitet | Truist | Buy |
| 2021-05-24 | Eingeleitet | William Blair | Outperform |
Alle ansehen
Privia Health Group Inc Aktie (PRVA) Neueste Nachrichten
Privia Health Group (PRVA) Projected to Post Quarterly Earnings on Thursday - Defense World
(PRVA) Technical Pivots with Risk Controls - Stock Traders Daily
Privia Health's SWOT analysis: stock's steady growth amid healthcare challenges - MSN
Privia Health Group’s (PRVA) “Market Outperform” Rating Reiterated at JMP Securities - Defense World
Yousif Capital Management LLC Trims Stake in Privia Health Group, Inc. (NASDAQ:PRVA) - Defense World
Privia Health Group (NASDAQ:PRVA) Earns "Market Outperform" Rating from JMP Securities - MarketBeat
In 2025, Privia Health Group Inc (NASDAQ: PRVA) Shares Will Likely Be Bullish - Stocks Register
Bleakley Financial Group LLC Trims Holdings in Privia Health Group, Inc. (NASDAQ:PRVA) - MarketBeat
Privia Health Group (NASDAQ:PRVA) Reaches New 52-Week HighShould You Buy? - MarketBeat
What Analysts Are Saying About Privia Health Gr Stock - Benzinga
Top 10 Health Information Services Stocks Outpacing The Market In 2025 - Insider Monkey
Privia Health Group, Inc. (PRVA): Among the Health Information Services Stocks Outpacing the Market in 2025 - Insider Monkey
Privia Health stock hits 52-week high at $24.16 amid growth - Investing.com Nigeria
Choreo LLC Purchases 1,752 Shares of Privia Health Group, Inc. (NASDAQ:PRVA) - Defense World
Privia Health stock hits 52-week high at $24.16 amid growth By Investing.com - Investing.com South Africa
Bleakley Financial Group LLC Sells 12,965 Shares of Privia Health Group, Inc. (NASDAQ:PRVA) - Defense World
Privia Health Group (NASDAQ:PRVA) Hits New 52-Week HighWhat's Next? - MarketBeat
How the (PRVA) price action is used to our Advantage - Stock Traders Daily
Janney Montgomery Scott LLC Lowers Stake in Privia Health Group, Inc. (NASDAQ:PRVA) - Defense World
Privia Health Group, Inc. (NASDAQ:PRVA) Receives $24.88 Average PT from Brokerages - MarketBeat
Fifth Third Bancorp Has $100,000 Stake in Privia Health Group, Inc. (NASDAQ:PRVA) - Defense World
Privia Health Group, Inc. (NASDAQ:PRVA) Receives Consensus Recommendation of “Buy” from Brokerages - Defense World
Privia Health Group, Inc. (NASDAQ:PRVA) Position Increased by Nisa Investment Advisors LLC - Defense World
Park Avenue Securities LLC Increases Stock Holdings in Privia Health Group, Inc. (NASDAQ:PRVA) - Defense World
Privia Health to Report Fourth Quarter 2024 Results on Thursday, February 27 - The Manila Times
Privia Health to Report Fourth Quarter 2024 Results on Thursday, February 27 - GlobeNewswire Inc.
Privia Health Group, Inc. (NASDAQ:PRVA) Shares Purchased by Riverbridge Partners LLC - MarketBeat
Privia Health stock hits 52-week high at $23.38 amid market optimism - Investing.com Australia
Privia Health Group (NASDAQ:PRVA) Sets New 1-Year HighHere's What Happened - MarketBeat
An Intrinsic Calculation For Privia Health Group, Inc. (NASDAQ:PRVA) Suggests It's 49% Undervalued - Yahoo Finance
JPMorgan Chase & Co. Boosts Stock Position in Privia Health Group, Inc. (NASDAQ:PRVA) - MarketBeat
JPMorgan Chase & Co. Has $3.43 Million Stock Position in Privia Health Group, Inc. (NASDAQ:PRVA) - Defense World
Learn to Evaluate (PRVA) using the Charts - Stock Traders Daily
Critical Analysis: Vsee Health (NASDAQ:VSEE) & Privia Health Group (NASDAQ:PRVA) - Defense World
Privia Health Group, Inc. (NASDAQ:PRVA) Shares Sold by Harbor Capital Advisors Inc. - Defense World
Insiders At Privia Health Group Sold US$898k In Stock, Alluding To Potential Weakness - Simply Wall St
Privia Health Group (NASDAQ:PRVA) Research Coverage Started at Needham & Company LLC - Defense World
Needham Initiates Coverage of Privia Health Group (PRVA) with Buy Recommendation - MSN
Privia Health stock backed by Needham for strong 2025 outlook in VBC space - Investing.com Australia
Privia Health Group (NASDAQ:PRVA) Earns Buy Rating from Analysts at Needham & Company LLC - MarketBeat
Nordea Investment Management AB Purchases 86,910 Shares of Privia Health Group, Inc. (NASDAQ:PRVA) - MarketBeat
Privia Health Group, Inc. (NASDAQ:PRVA) Receives $24.88 Consensus Target Price from Analysts - MarketBeat
Privia Health Group, Inc. (NASDAQ:PRVA) Given Average Rating of “Buy” by Brokerages - Defense World
Privia Health Group (NASDAQ:PRVA) Receives “Overweight” Rating from Stephens - Defense World
A Glimpse Into The Expert Outlook On Privia Health Gr Through 6 Analysts - Benzinga
Finanzdaten der Privia Health Group Inc-Aktie (PRVA)
Umsatz
Nettogewinn
Free Cashflow
ENV
4.46%
2.95%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):